Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The purpose of this study it to learn the effects (good or bad) that rosiglitazone has on patients and their prostate cancer. This study is going to look at what effects rosiglitazone has on prostate specific antigen (PSA) levels.
Epistemonikos ID: 77b29805eb138c4198f9eb943a39d86a537feb96
First added on: May 04, 2024